J. Gaitan

Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.

P. Coursaget, P. Sizaret, A. Touzé, 2008, Vaccine.

Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies

P. Coursaget, Nicolas Combelas, A. Touzé, 2010, Journal of Translational Medicine.

Merkel Cell Polyomavirus Strains in Patients with Merkel Cell Carcinoma

P. Coursaget, C. Clavel, F. Aubin, 2009, Emerging infectious diseases.

Generation of Merkel Cell Polyomavirus (MCV)-Like Particles and Their Application to Detection of MCV Antibodies

P. Coursaget, M. Tognon, Nicolas Combelas, 2010, Journal of Clinical Microbiology.

Seroprevalence of Antibodies against Human Papillomavirus (HPV) Types 16 and 18 in Four Continents: the International Agency for Research on Cancer HPV Prevalence Surveys

P. Coursaget, S. Franceschi, N. Muñoz, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Inhibition of cervical cancer cell growth by human papillomavirus virus–like particles packaged with human papillomavirus oncoprotein short hairpin RNAs

P. Coursaget, G. Gaud, P. Sizaret, 2009, Molecular Cancer Therapeutics.

Merkel cell polyomavirus strains in patients with merkel cell carcinoma.

P. Coursaget, C. Clavel, A. Maruani, 2009 .

Seroprevalence of Antibodies against Human Papillomavirus (HPV) Types 16 and 18 in Four Continents: the International Agency for Research on Cancer HPV Prevalence Surveys

P. Coursaget, S. Franceschi, N. Muñoz, 2010, Cancer Epidemiology, Biomarkers & Prevention.